Jason Valent
Experienced in IgG4-Related Disease

Dr. Jason Valent

Hematology Oncology | Hematology | Oncology
Cleveland Clinic
Cleveland Clinic Main Campus
9500 Euclid Avenue, 
Cleveland, OH 
On Staff At
Offers Telehealth

Experienced in IgG4-Related Disease
Cleveland Clinic
Cleveland Clinic Main Campus
9500 Euclid Avenue, 
Cleveland, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jason Valent is a Hematologist Oncology specialist and a Hematologist in Cleveland, Ohio. Dr. Valent is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Waldenstrom Macroglobulinemia, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 72 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in OH
Hospital Affiliations
Hillcrest Hospital
Cleveland Clinic
Mercy Medical Center
Medina Hospital
Akron General Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
SummaCare
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Cleveland Clinic Main Campus
9500 Euclid Avenue, Cleveland, OH 44195

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients With Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)
S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients With Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Lenalidomide, Daratumumab/rHuPH20
Study Phase: Phase 3
A Phase II Study of Isatuximab (SAR650984) (NSC-795145) for Patients With Previously Treated AL Amyloidosis
A Phase II Study of Isatuximab (SAR650984) (NSC-795145) for Patients With Previously Treated AL Amyloidosis
Enrollment Status: Completed
Publish Date: September 09, 2025
Intervention Type: Other, Biological
Study Drug: Isatuximab
Study Phase: Phase 2
A Phase 1b Trial of Vactosertib in Combination With Pomalidomide (POM) in Relapsed or Relapsed and Refractory Multiple Myeloma (RRMM)
A Phase 1b Trial of Vactosertib in Combination With Pomalidomide (POM) in Relapsed or Relapsed and Refractory Multiple Myeloma (RRMM)
Enrollment Status: Completed
Publish Date: May 24, 2024
Intervention Type: Drug
Study Drugs: Vactosertib, Pomalidomide
Study Phase: Phase 1
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study of NEOD001 Plus Standard of Care Versus Placebo Plus Standard of Care in Subjects With Light Chain (AL) Amyloidosis
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study of NEOD001 Plus Standard of Care Versus Placebo Plus Standard of Care in Subjects With Light Chain (AL) Amyloidosis
Enrollment Status: Terminated
Publish Date: November 14, 2023
Intervention Type: Other, Drug
Study Phase: Phase 3
A Randomized Multicenter Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma
A Randomized Multicenter Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma
Enrollment Status: Terminated
Publish Date: November 21, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Who Have Persistent Cardiac Dysfunction
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Who Have Persistent Cardiac Dysfunction
Enrollment Status: Completed
Publish Date: April 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2b Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of NEOD001 in Subjects With Light Chain (AL) Amyloidosis Who Were Previously Enrolled in Study NEOD001-201 (PRONTO)
A Phase 2b Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of NEOD001 in Subjects With Light Chain (AL) Amyloidosis Who Were Previously Enrolled in Study NEOD001-201 (PRONTO)
Enrollment Status: Terminated
Publish Date: March 26, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

72 Total Publications

Management of relapsed refractory multiple myeloma: Evidence-based guide to community oncologists.
Management of relapsed refractory multiple myeloma: Evidence-based guide to community oncologists.
Journal: Blood reviews
Published: July 25, 2025
View All 72 Publications
Similar Doctors
Brian T. Hill
Experienced in IgG4-Related Disease
Dr. Brian T. Hill
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Brian T. Hill
Hematology Oncology | Hematology | Oncology

Cleveland Clinic Main Campus

10201 Carnegie Avenue, 
Cleveland, OH 
 (0.3 miles away)
866-223-8100
Experience:
30+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Brian Hill is a Hematologist Oncology specialist and a Hematologist in Cleveland, Ohio. Dr. Hill has been practicing medicine for over 30 years and is rated as an Elite provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Shahzad Raza
Experienced in IgG4-Related Disease
Dr. Shahzad Raza
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Shahzad Raza
Hematology Oncology | Hematology | Oncology

Cleveland Clinic Main Campus

10201 Carnegie Avenue, 
Cleveland, OH 
 (0.3 miles away)
866-223-8100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Shahzad Raza is a Hematologist Oncology specialist and a Hematologist in Cleveland, Ohio. Dr. Raza is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Primary Amyloidosis, Bone Marrow Aspiration, and Tissue Biopsy.

Experienced in IgG4-Related Disease
Dr. Mukesh C. Bhatt
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Mukesh C. Bhatt
Hematology Oncology | Hematology | Oncology

University Primary Care Practices Inc

970 E Washington St, Suite 4d, 
Medina, OH 
 (27.5 miles away)
330-722-5420
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Mukesh Bhatt is a Hematologist Oncology specialist and a Hematologist in Medina, Ohio. Dr. Bhatt is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Familial Colorectal Cancer, Anemia, Thrombocytopenia, and Childhood Iron Deficiency Anemia. Dr. Bhatt is currently accepting new patients.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Valent's expertise for a condition
ConditionClose
  • Elite
  • Multiple Myeloma
    Dr. Valent is
    Elite
    . Learn about Multiple Myeloma.
    See more Multiple Myeloma experts
  • Primary Amyloidosis
    Dr. Valent is
    Elite
    . Learn about Primary Amyloidosis.
    See more Primary Amyloidosis experts
  • Distinguished
  • Cardiac Amyloidosis
    Dr. Valent is
    Distinguished
    . Learn about Cardiac Amyloidosis.
    See more Cardiac Amyloidosis experts
  • Familial Transthyretin Amyloidosis
    Dr. Valent is
    Distinguished
    . Learn about Familial Transthyretin Amyloidosis.
    See more Familial Transthyretin Amyloidosis experts
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
    Dr. Valent is
    Distinguished
    . Learn about Monoclonal Gammopathy of Undetermined Significance (MGUS).
    See more Monoclonal Gammopathy of Undetermined Significance (MGUS) experts
  • Relapsed Refractory Multiple Myeloma (RRMM)
    Dr. Valent is
    Distinguished
    . Learn about Relapsed Refractory Multiple Myeloma (RRMM).
    See more Relapsed Refractory Multiple Myeloma (RRMM) experts
  • Schnitzler Syndrome
    Dr. Valent is
    Distinguished
    . Learn about Schnitzler Syndrome.
    See more Schnitzler Syndrome experts
  • Smoldering Multiple Myeloma
    Dr. Valent is
    Distinguished
    . Learn about Smoldering Multiple Myeloma.
    See more Smoldering Multiple Myeloma experts
View All 7 Distinguished Conditions
  • Advanced
  • Cerebral Amyloid Angiopathy
    Dr. Valent is
    Advanced
    . Learn about Cerebral Amyloid Angiopathy.
    See more Cerebral Amyloid Angiopathy experts
  • Cryoglobulinemia
    Dr. Valent is
    Advanced
    . Learn about Cryoglobulinemia.
    See more Cryoglobulinemia experts
  • Diffuse Large B-Cell Lymphoma (DLBCL)
    Dr. Valent is
    Advanced
    . Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
    See more Diffuse Large B-Cell Lymphoma (DLBCL) experts
  • Familial Mixed Cryoglobulinemia
    Dr. Valent is
    Advanced
    . Learn about Familial Mixed Cryoglobulinemia.
    See more Familial Mixed Cryoglobulinemia experts
  • Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency
    Dr. Valent is
    Advanced
    . Learn about Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency.
    See more Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency experts
  • GTP Cyclohydrolase 1 Deficiency
    Dr. Valent is
    Advanced
    . Learn about GTP Cyclohydrolase 1 Deficiency.
    See more GTP Cyclohydrolase 1 Deficiency experts
View All 16 Advanced Conditions
  • Experienced
  • Acute Eosinophilic Pneumonia
    Dr. Valent is
    Experienced
    . Learn about Acute Eosinophilic Pneumonia.
    See more Acute Eosinophilic Pneumonia experts
  • Acute Myeloblastic Leukemia with Maturation
    Dr. Valent is
    Experienced
    . Learn about Acute Myeloblastic Leukemia with Maturation.
    See more Acute Myeloblastic Leukemia with Maturation experts
  • Acute Myeloblastic Leukemia without Maturation
    Dr. Valent is
    Experienced
    . Learn about Acute Myeloblastic Leukemia without Maturation.
    See more Acute Myeloblastic Leukemia without Maturation experts
  • Acute Myeloid Leukemia (AML)
    Dr. Valent is
    Experienced
    . Learn about Acute Myeloid Leukemia (AML).
    See more Acute Myeloid Leukemia (AML) experts
  • Adult Immune Thrombocytopenia
    Dr. Valent is
    Experienced
    . Learn about Adult Immune Thrombocytopenia.
    See more Adult Immune Thrombocytopenia experts
  • Agranulocytosis
    Dr. Valent is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
View All 74 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved